ASCO GU 2019 - Dr. Andrew J. Armstrong, Duke University, NC, USA

preview_player
Показать описание
Phase 3 study of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): The ARCHES trial.
Рекомендации по теме